Status:
SUSPENDED
A Real-world Clinical Study of Kapok Initiative
Lead Sponsor:
Chinese Academy of Medical Sciences
Collaborating Sponsors:
QTC care
Conditions:
Quality of Life
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study is a prospective and effective research study. The aim is to assess the difference in the quality of life of the family members of patients with colorectal cancer after application of follo...
Eligibility Criteria
Inclusion
- (1) Subject: The main family members caring for patients are ≥18 and ≤65 years old;
- (2) Family members of patients who can understand the purpose of the study, voluntarily participate and sign an informed consent form, and are willing to complete follow-up as required by the protocol;
- (3) Family members of colorectal cancer patients who need to receive adjuvant chemotherapy XELOX regimen within 6 months after initial diagnosis of high-risk stage II or stage III
Exclusion
- (1) Patient life expectancy is less than 3 months
- (2) Family members of patients cannot use electronic mobile products
- (3) The family of the patient has a history of malignant tumors or other serious diseases
- (4) Family members of patients are considered unsuitable by the researcher
Key Trial Info
Start Date :
May 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04735991
Start Date
May 8 2020
End Date
October 1 2022
Last Update
February 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Beijing, China, 100021